Ⓒ Copyright 2022 ABC Global Alliance
VAT/NIPC 515 732 230
Sign up to the newsletter
Oops! Something went wrong while submitting the form.
Considering that nearly one in three individuals with metastatic breast cancer may face brain metastases, our collaboration with Seagen has led to the creation of an informative video about brain metastases. This resource offers valuable insights into how these metastases develop, how to recognize them, and when it's essential to seek guidance from your healthcare providers.
Explore.png)
.png)
• NAVIGATING CLINICAL TRIALS
• DEMYSTIFYING TERMINOLOGY
• CARING FOR OUR CAREGIVERS
• MAXIMIZING COMMUNICATION WITH YOUR DOCTOR
• PARENTING WITH MBC
• SUPPORTIVE AND PALLIATIVE CARE
To address the critical unmet need in access to care for hard-to-reach populations with advanced/ metastatic breast cancer (ABC/MBC), the ABC Global Alliance and Pfizer have collaborated to develop a toolkit of relevant, community-based initiatives and best practice summary documents that aims to drive collaboration across the global ABC/MBC community.
People with advanced/metastatic breast cancer (ABC/MBC) require an understanding of the biomarkers relevant to their diagnosis to actively engage in shared decision-making with their healthcare team. It may also help to alleviate some of the uncertainty that comes with a diagnosis and improve patient-reported outcomes.
ABC Global Alliance partnered with AstraZeneca to develop a global survey of people with ABC/MBC, investigating their understanding and recall of related biomarkers, and their experiences and challenges in learning about the type of breast cancer they have. The survey culminated in the development of a whitepaper outlining key challenges and opportunities for change to empower patients with the knowledge and information to take an active role in their own care.
This study and the accompanying whitepaper were developed and funded by AstraZeneca, in partnership with ABC Global Alliance. Z4-65060. Date of Preparation: May 2024.
A Navigator proactively collaborates with a patient and provides guidance with the complex issues of health, services and potential barriers throughout the cancer experience.
Learn More
Over the past two years, the international multidisciplinary group of experts, including our President, Dr Fatima Cardoso, has worked to transform the breast cancer care landscape. The Lancet Commission on Breast Cancer, launched in April 2024, released findings and recommendations on improving breast cancer care globally has led debate around key issues, supported pilot studies, culminating it its landmark report to help reduce the impact of breast cancer on society.
Recent progress in research and treatment has helped reduce the number of deaths from breast cancer, with decreases of up to 40% in some high-income countries. However, breast cancer still poses an enormous burden worldwide, with the Commission stating, “society, governments and decision-makers in the health sector only see the tip of an iceberg.”
Inequities in healthcare, along with the hidden costs of breast cancer, mean that many women and some men are being left behind and forgotten. This is a global problem, with the Commission highlighting key barriers that prevent progress in its report advocating for six crucial areas for change.